Literature DB >> 31076364

Ovarian cancer: time to move beyond one size fits all.

Angeles Alvarez Secord1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31076364     DOI： 10.1016/S1470-2045(19)30285-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Exosomal microRNA‑146a derived from mesenchymal stem cells increases the sensitivity of ovarian cancer cells to docetaxel and taxane via a LAMC2‑mediated PI3K/Akt axis.

Authors:  Liya Qiu; Jiakun Wang; Mei Chen; Fengyun Chen; Wenluo Tu
Journal:  Int J Mol Med       Date:  2020-06-05       Impact factor: 4.101

2.  IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells via Aryl Hydrocarbon Receptor Activation.

Authors:  Adaobi Amobi-McCloud; Ravikumar Muthuswamy; Sebastiano Battaglia; Han Yu; Tao Liu; Jianmin Wang; Vasanta Putluri; Prashant K Singh; Feng Qian; Ruea-Yea Huang; Nagireddy Putluri; Takemasa Tsuji; Amit A Lugade; Song Liu; Kunle Odunsi
Journal:  Front Immunol       Date:  2021-04-16       Impact factor: 8.786
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.